3Kelly WM,Goldstein D.Hypersensitiviy reactions to oxaliplatin:can patients be rechallenged[J].Asia-Pacific Journal of Clinical Oncology,2006,2(4):175-179.
2Kelly WM, Goldstein D. Hypersensitivity reactions to oxaliplatin : can patients be rechallenged [ J ] ? Asia - Pacific Journal of Clinical Oncology, 2006,2(4) :175 - 179.
3Maindrauh - Goebel F, Andre T, Tournigand C, et al. Allergic - type reactions to oxaliplatin : retrospective anatysisof 42 patients[ J ]. Eur J Cancer, 2005,41 ( 15 ) :2262 - 2267.
4Kitada N, Dan T, Takara K, et al. Oxaliplatin - induced hypersensitivity reaction displaying marked elevation of immunoglobulin E[ J]. J Oncol Pharm Pract ,2007,13 ( 4 ) :233 - 235.
5Santini D, Tonini G, Vincenzi B, et al. Idiosyncratic reaction after oxaliplatin infusion[ J]. Ann Oncol,2001,12 : 132 - 133.
6Thomas RR , Quinn MG, Schuler B , et al. Hypersensitivity and idiosyncratic reactions to oxaliplatin [ J ]. Cancer , 2003 , 97 (9) : 2301 - 2307.
8de Gramont A, Figer A,Seymour M ,et al. Leucovorin and flaorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer[J]. J Clin Oncol, 2000,18(16) :2938 -2947.
9Goldberg RM. N9741 : a phase Ⅲ study comparing irinotecan to oxaliplatin-containing regimens in advanced coloreetal cancer[ J ]. Clin Colorectal Cancer, 2002,2(2) :81.
10Brandi G, Pantaleo MA, Galli C, et al. Hypersensitivity reactions related to oxaliplatin (OHP) [J].Br J Cancer,2003,89(3) :477 -481.
3TONINI G, SANTINI D, VINGENZI B, et al. Oxaliplatin may induce eytokine-release syndrome in colorectal cancer patients[J]. J Biol Regul Homeost Agents, 2002, 16(2): 105-109.
4MOK KW, GOLDSTEIN D. Hypersensitiviy reactions to oxaliplatin; can pa-tients be rechallenged[J]. Asia-Pacific J Clin Oncol, 2006, 2(4): 175-179.
5THOMAS RR, QUINN MG, SCHULER B, et ol. Hypersen- sitivity and idiosyncratic reactions to oxaliplatin[J]. Cancer, 2003, 97(9) : 2301-2307.
6POLYZOS A, TSAVARIS N, GOGAS H, et ol. Clinical features of hypersensitivity reactions to oxaliplatin: a 10-year experience [J]. Oncology, 2009, 76(1): 36-41.
7PAGANI M, BONADONNA P, SENNA G E, et al. Stand- ardization of skin tests for diagnosis and prevention of hypersen- sitivity reactions to oxaliplatin[J]. Int Arch Allergy Immunol, 2008, 145(1) : 54-57.
8MEYER L, ZUBETHIER T, WBRM M, et 01. Hypersensitivity reactions to oxaliplatin: eross- reactivity to carboplatin and the introduction of a desensitization schedule[J]. J Clin Oncol, 2002, 20(4) : 1146-1147.
9LIM KH, HUANG MJ, LIN HC, et al. Hypersensitivity reactions to oxaliplatin: a ease report and the success of a continuous infusional desensitization schedule[J]. Anticaneer Drugs, 2004, 15 (6) : 605-607.
10BHARGAVA P, GAMMON D, MCCORMICK MJ. Hypersensi- tivity and idiosyncratic reactions to oxaliplatin. Cancer, 2004, 100(1): 211-212.
